MOUNTING criticism of pharmaceutical firms could result in tough regulatory action that would hit investor returns, governance experts warn.
F&C Asset Management says drug firms are facing allegations of putting profits before patient safety, exerting inappropriate influence on regulations and unethical behaviour in the sales and marketing...
The Next Generation Pensions Committee is on a mission to promote and encourage younger voices in the industry. Kim Kaveh looks at its key objectives
This week's top stories included an analysis finding the cost of equalising guaranteed minimum pensions in schemes could hit FTSE 100 profits by up to £15bn.
Employers whose dividend to deficit recovery contribution (DRCs) ratios fall outside the "normal range" should expect to see higher regulatory scrutiny, although no fixed ratio will be set.
Investment consultants and fiduciary managers should expect a final decision on the investigation into the market to be published by the end of the year, the competition watchdog says.